Search Results

The Cardiology Cath Lab in the COVID-19 Era

Evaluating the steps from pre- to postprocedure to ensure patient and staff safety.

By Sara C. Martinez, MD, PhD, FACC

Future Focus: Predictions for the Cardio-Oncology Field in 10 Years

The next decade of cardio-oncology is likely to include an increased presence in training programs, more outcomes data for intervention in specific cardiovascular presentations, improved patient quality of life, and importantly, greater influence on interventional cardiology.

With Orly Leiva Jr, MD, and Sara C. Martinez, MD, PhD, FACC, FSCAI

Transcatheter Solutions for Mitral/Tricuspid Valves

By Fabien Praz, MD, and Rishi Puri, MD

Left Main Disease and Bifurcation Revascularization in Female Patients

A review of current data and female representation in clinical trials evaluating left main coronary artery disease and bifurcation lesion revascularization.

By Tara L. Jones, MD, PharmD, and Valeria Paradies, MD

Clinical Utility of Cardiac CTA

The current role and cost effectiveness of this modality.

By Sunil Mirchandani, MD, and James K. Min, MD

TAV-in-TAV: Future Considerations for Intermediate- and Low-Risk Patients

Challenges to the transcatheter management of severe aortic stenosis across a lifetime.

By Akshay Kamath, MD; Shravan Rao, MD; Brett Sheridan, MD; Christian Spies, MD; and David Daniels, MD

Bare-Metal Stents for Primary PCI

Challenging the myths with evidence.

By Ander Regueiro, MD, and Manel Sabaté,, MD, PhD

Heterotopic Transcatheter Tricuspid Valve Implantation

A promising technology for patients with high-risk TR.

By Omar Abdul-Jawad Altisent, MD, PhD, and Rodrigo Estévez-Loureiro, MD, PhD